Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
08 Feb 2018 Patient Specific HLA Class I Genotype Influences Response to Immune Checkpoint Inhibitors Translational research - Cancer Immunology and Immunotherapy
07 Feb 2018 NICE Publishes Technology Appraisal Guidance About Intrabeam Radiotherapy System for Adjuvant Treatment of Early Breast Cancer Breast cancer
06 Feb 2018 CAR T-Cell Therapy Provides High Remission Rate in Paediatric and Young Adult Patients with Relapsed or Refractory B-Cell ALL Cancer in Special Situations / Population - Cancer Immunology and Immunotherapy
05 Feb 2018 2017 Progress in Oncology Clinical Science Breast cancer - Lung and other thoracic tumours - Gastrointestinal cancers - Genitourinary cancers - Melanoma and other skin tumours - Haematologic malignancies - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
03 Feb 2018 ESMO Press Release: ESMO Supports World Cancer Day 2018
02 Feb 2018 Gut Bacteria Can Affect Patient Responses to Anti-PD1 Immunotherapy Translational research - Cancer Immunology and Immunotherapy
01 Feb 2018 Fusions in Solid Tumours Pathology/Molecular biology - Personalised medicine
31 Jan 2018 ESMO Supports World Cancer Day 2018
31 Jan 2018 FDA Approves Lutetium Lu 177 Dotatate for Treatment of GEP NETs Endocrine and neuroendocrine tumours
30 Jan 2018 Withdrawal of the EU Marketing Authorisation Application for Binimetinib Melanoma and other skin tumours - Anticancer agents & Biologic therapy
29 Jan 2018 Withdrawal of the Application for a Change to the EU Marketing Authorisation for Nivolumab Gastrointestinal cancers - Cancer Immunology and Immunotherapy
26 Jan 2018 NICE Issues Technology Appraisal Guidance on Lenvatinib with Everolimus for Previously Treated Advanced RCC Genitourinary cancers - Anticancer agents & Biologic therapy
25 Jan 2018 NICE Publishes a Technology Appraisal Guidance for Ceritinib for Untreated ALK-positive NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
24 Jan 2018 EMA Recommends Refusal of the Marketing Authorisation for Plitidepsin Haematologic malignancies - Anticancer agents & Biologic therapy
23 Jan 2018 NICE Develops a Medtech Innovation Briefing on the MammaTyper In Vitro Diagnostic Test Breast cancer - Pathology/Molecular biology - Personalised medicine